C. R. Jack, Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, pp.207-216, 2013.

E. Morris, Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, Eur. J. Nucl. Med. Mol. Imaging, vol.43, pp.374-385, 2016.

J. Maeda, Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography, J. Neurosci. Off. J. Soc. Neurosci, vol.27, pp.10957-10968, 2007.

W. E. Klunk, Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.10598-10606, 2005.

A. Snellman, Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswePS1dE9 mouse models of Alzheimer disease, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.54, pp.1434-1441, 2013.

S. Rojas, In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography, Neurobiol. Aging, vol.34, pp.1790-1798, 2013.

C. Kuntner, Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease, Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging, vol.11, pp.236-240, 2009.

G. Poisnel, PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition, Neurobiol. Aging, vol.33, pp.2561-2571, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01853953

M. Hintersteiner, In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe, Nat. Biotechnol, vol.23, pp.577-583, 2005.

J. Dong, R. Revilla-sanchez, S. Moss, and P. G. Haydon, Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease, Neuropharmacology, vol.59, pp.268-275, 2010.

B. Delatour, S. Epelbaum, A. Petiet, and M. Dhenain, In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?, Int. J. Alzheimers Dis, p.2010, 2010.

C. R. Jack, In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent, Magn. Reson. Med, vol.52, pp.1263-1271, 2004.

A. Borthakur, In vivo measurement of plaque burden in a mouse model of Alzheimer's disease, J. Magn. Reson. Imaging JMRI, vol.24, pp.1011-1017, 2006.

R. Chamberlain, Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibilityweighted imaging methods in transgenic mouse models of Alzheimer's disease, Magn. Reson. Med, vol.61, pp.1158-1164, 2009.

M. Dhenain, Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice, Neurobiol. Aging, vol.30, pp.41-53, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00320356

H. Benveniste, G. Einstein, K. R. Kim, C. Hulette, and G. A. Johnson, Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy, Proc. Natl. Acad. Sci. USA, vol.96, pp.14079-14084, 1999.

T. Nakada, H. Matsuzawa, H. Igarashi, Y. Fujii, and I. L. Kwee, In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system, J. Neuroimaging Off. J. Am. Soc. Neuroimaging, vol.18, pp.125-129, 2008.

M. D. Meadowcroft, J. R. Connor, M. B. Smith, and Q. X. Yang, MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice, J. Magn. Reson. Imaging JMRI, vol.29, pp.997-1007, 2009.

M. F. Falangola, S. Lee, R. A. Nixon, K. Duff, and J. A. Helpern, Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice, Neurochem. Res, vol.30, pp.201-205, 2005.

M. Dhenain, N. Privat, C. Duyckaerts, and R. E. Jacobs, Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images, NMR Biomed, vol.15, pp.197-203, 2002.

M. M. Zeineh, Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease, Neurobiol. Aging, vol.36, pp.2483-2500, 2015.

J. F. Poduslo, Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging, Neurobiol. Dis, vol.11, pp.315-329, 2002.

M. Higuchi, 19F and 1H MRI detection of amyloid beta plaques in vivo, Nat. Neurosci, vol.8, pp.527-533, 2005.

E. M. Sigurdsson, A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice, Neurobiol. Aging, vol.29, pp.836-847, 2008.

Y. Z. Wadghiri, Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging, PloS One, vol.8, p.57097, 2013.

A. Petiet, Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice, Neurobiol. Aging, vol.33, pp.1533-1544, 2012.

M. D. Santin, T. Debeir, S. L. Bridal, T. Rooney, and M. Dhenain, Fast in vivo imaging of amyloid plaques using ?-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening, NeuroImage, vol.79, pp.288-294, 2013.

M. Dhenain, B. Delatour, C. Walczak, and A. Volk, Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease, Magn. Reson. Med, vol.55, pp.687-693, 2006.

M. D. Santin, In vivo detection of amyloid plaques by Gadolinium-stained MRI can be used to demonstrate the efficacy of an anti-amyloid immunotherapy, Front. Aging Neurosci, vol.8, p.55, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02155734

A. Bertrand, Micro-MRI study of cerebral aging: ex vivo detection of hippocampal subfield reorganization, microhemorrhages and amyloid plaques in mouse lemur primates, PloS One, vol.8, p.56593, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01407046

H. Hyare, P. So, S. Brandner, J. Collinge, and H. G. Parkes, MRI detection of prion protein plaques in variant Creutzfeldt-Jakob disease, Neurology, vol.84, pp.1498-1499, 2015.

S. Love and J. S. Miners, Cerebrovascular disease in ageing and Alzheimer's disease, Acta Neuropathol. (Berl.), vol.131, pp.645-658, 2016.

J. Barakos, MR Imaging Features of Amyloid-Related Imaging Abnormalities, Am. J. Neuroradiol, vol.34, pp.1958-1965, 2013.

N. Beckmann, C. Gerard, D. Abramowski, C. Cannet, and M. Staufenbiel, Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy, J. Neurosci, vol.31, pp.1023-1031, 2011.

F. Luo, Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice, J. Pharmacol. Exp. Ther, vol.335, pp.580-588, 2010.

K. A. Gyure, R. Durham, W. F. Stewart, J. E. Smialek, and J. C. Troncoso, Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome, Arch. Pathol. Lab. Med, vol.125, pp.489-492, 2001.

G. K. Gouras, Intraneuronal Abeta42 accumulation in human brain, Am. J. Pathol, vol.156, pp.15-20, 2000.

F. M. Laferla, K. N. Green, and S. Oddo, Intracellular amyloid-beta in Alzheimer's disease, Nat. Rev. Neurosci, vol.8, pp.499-509, 2007.

C. R. Jack, In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.10041-10048, 2005.

R. J. Nabuurs, High-field MRI of single histological slices using an inductively coupled, self-resonant microcoil: application to ex vivo samples of patients with Alzheimer's disease, NMR Biomed, vol.24, pp.351-357, 2011.

M. Schrag, C. Mueller, U. Oyoyo, M. A. Smith, and W. M. Kirsch, Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion, Prog. Neurobiol, vol.94, pp.296-306, 2011.

T. M. Wengenack, Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain, NeuroImage, vol.54, pp.113-122, 2011.

, Scientific RepoRts |, vol.7

R. J. Nabuurs, MR microscopy of human amyloid-? deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid, J. Alzheimers Dis. JAD, vol.34, pp.1037-1049, 2013.

V. Blanchard, Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice, Exp. Neurol, vol.184, pp.247-263, 2003.

J. L. Jankowsky, Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum. Mol. Genet, vol.13, pp.159-170, 2004.

M. Garcia-alloza, Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease, Neurobiol. Dis, vol.24, pp.516-524, 2006.

C. Sturchler-pierrat, Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc. Natl. Acad. Sci. USA, vol.94, pp.13287-13292, 1997.

M. E. Calhoun, Neuron loss in APP transgenic mice, Nature, vol.395, pp.755-756, 1998.

J. Davis, Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor, J. Biol. Chem, vol.279, pp.20296-20306, 2004.

S. Oddo, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron, vol.39, pp.409-421, 2003.

G. Paxinos and K. B. Franklin, The mouse brain in stereotaxic coordinates, 2001.

C. D. Thomas, Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice, Magn. Reson. Med, vol.50, pp.522-530, 2003.

K. A. Berghorn, J. H. Bonnett, and G. E. Hoffman, cFos immunoreactivity is enhanced with biotin amplification, J. Histochem. Cytochem. Off. J. Histochem. Soc, vol.42, pp.1635-1642, 1994.

N. El-tannir-el-tayara, Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease, Neurobiol. Dis, vol.22, pp.199-208, 2006.

C. A. Schneider, W. S. Rasband, K. W. Eliceiri, and . Nih, Image to ImageJ: 25 years of image analysis, Nat. Methods, vol.9, pp.671-675, 2012.